By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it will redeem all of its outstanding 3.25 percent convertible senior subordinated notes due 2024.

The firm said that $329,229,000 million in aggregate principal amount of the notes was outstanding as of Feb. 25, 2011. The notes will be redeemed on March 30 at 100 percent of their principal amount plus accrued and unpaid interest to the redemption date, said Thermo Fisher.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.